• Explore /
  • Poster
  • / Safety outcomes in patients with metastatic castration-resistant prostate cancer treated with radium-223 following external beam radiation therapy: REASSURE US subset.

Safety outcomes in patients with metastatic castration-resistant prostate cancer treated with radium-223 following external beam radiation therapy: REASSURE US subset.

Abstract Poster

Authors

A. Sartor

A. Oliver Sartor

Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA

A. Oliver Sartor , Peter Conti , Mary-Ellen Taplin , Daniel Song , Saby George , Jeffrey John Tomaszewski , John Sylvester , Constantine Anastasios Mantz , Robert Given , Robert K. Brookland , Jeffrey Meltzer , Matthew J. Korn , Jacqueline Parkin , Svetlana Babajanyan , Celestia S. Higano

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 106)

DOI

10.1200/JCO.2024.42.4_suppl.106

Abstract #

106

Poster Bd #

D21

Abstract Disclosures

Similar Posters

First Author: Celestia S. Higano

First Author: Celestia S. Higano

First Author: Nicholas D. James

First Author: Daniel J. George